Annual Shareholders Equity
$8.51 M
+$8.08 M+1845.15%
December 31, 2023
Summary
- As of February 24, 2025, GDTC annual stockholders equity is $8.51 million, with the most recent change of +$8.08 million (+1845.15%) on December 31, 2023.
- During the last 3 years, GDTC annual shareholders equity has risen by +$8.15 million (+2266.94%).
- GDTC annual shareholders equity is now at all-time high.
Performance
GDTC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$7.49 M
-$1.03 M-12.04%
June 30, 2024
Summary
- As of February 24, 2025, GDTC quarterly stockholders equity is $7.49 million, with the most recent change of -$1.03 million (-12.04%) on June 30, 2024.
- Over the past year, GDTC quarterly shareholders equity has stayed the same.
- GDTC quarterly shareholders equity is now -22.88% below its all-time high of $9.71 million, reached on June 30, 2023.
Performance
GDTC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
GDTC Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1845.2% | 0.0% |
| 3 y3 years | +2266.9% | 0.0% |
| 5 y5 years | +2266.9% | 0.0% |
GDTC Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1845.2% | -22.9% | +1610.9% |
| 5 y | 5-year | at high | +2266.9% | -22.9% | +1610.9% |
| alltime | all time | at high | +2266.9% | -22.9% | +1610.9% |
CytoMed Therapeutics Limited Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $7.49 M(-12.0%) |
| Dec 2023 | $8.51 M(+1845.1%) | $8.51 M(-12.3%) |
| Jun 2023 | - | $9.71 M(+2118.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $437.70 K(-77.2%) | $437.70 K(-60.9%) |
| Jun 2022 | - | $1.12 M(-41.6%) |
| Dec 2021 | $1.92 M(+432.9%) | $1.92 M |
| Dec 2020 | $359.70 K | - |
FAQ
- What is CytoMed Therapeutics Limited annual stockholders equity?
- What is the all time high annual shareholders equity for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual shareholders equity year-on-year change?
- What is CytoMed Therapeutics Limited quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited quarterly shareholders equity year-on-year change?
What is CytoMed Therapeutics Limited annual stockholders equity?
The current annual shareholders equity of GDTC is $8.51 M
What is the all time high annual shareholders equity for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual stockholders equity is $8.51 M
What is CytoMed Therapeutics Limited annual shareholders equity year-on-year change?
Over the past year, GDTC annual stockholders equity has changed by +$8.08 M (+1845.15%)
What is CytoMed Therapeutics Limited quarterly stockholders equity?
The current quarterly shareholders equity of GDTC is $7.49 M
What is the all time high quarterly shareholders equity for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high quarterly stockholders equity is $9.71 M
What is CytoMed Therapeutics Limited quarterly shareholders equity year-on-year change?
Over the past year, GDTC quarterly stockholders equity has changed by $0.00 (0.00%)